In the "Science Meets Design" series, leaders of the world's most innovative and creative companies discuss the fascinating interface between science and design.
In episode 2, our CEO and founder Mark Kotter talks about the impact of synthetic biology on human cells and how our innovative technology can overcome one of the major bottlenecks for cell therapy - access to scalable, consistent human cells.
Watch the episode below!